Nephrogenic Systemic Fibrosis and the Effects of Gadolinium

Nephrogenic systemic fibrosis is a horrible disease thatonly be used to detect lesions in the liver.
has no viable treatment option. It is a side effect ofThe risk of developing nephrogenic systemic fibrosis is
gadolinium traces lingering in the body, usually frombased on the body's ability to purge the traces of
contrast agents commonly used during MRI scans.gadolinium from the body after the MRI scan. In a
MRI and MRA scans have become commonplace inhealthy body with fully functional kidneys, the body can
the medical profession because of their extraordinaryexpel the gadolinium from the body with a little time.
ability to produce very detailed images of the body'sHowever, if the kidneys are unable to function
internal soft tissue. It allows doctors to make accuratecorrectly, the gadolinium will remain in the body, possibly
diagnoses without having to cut open the patient totriggering the onset of NSF.
find any problems. On occasion, an MRI contrast agentBecause of this, people with severe kidney disease or
may be used to dramatically improve the quality of thefailure must be very cautious of gadolinium based
images when scanning.contrast agents if undergoing an MRI exam. Do not
The only contrast agents approved by the FDA areproceed unless it is clear that any possible kidney
gadolinium based. In most cases, they are all safe tocomplications will not put you at risk of developing NSF.
use, and will not pose any real threat to the patient.If it is your first time undergoing an MRI scan, it is highly
However, they can have very fatal side effects. Whilesuggested that you be screened for kidney problems
there are other types without gadolinium, those arebefore being administered a contrast agent to avoid
only approved by the FDA for very specific uses. Forthe side effects of gadolinium.
example, Feridex I.V. is an iron based agent that can